Mereo Biopharma Group Plc (0A9G) Ownership - Who Owns Mereo Biopharma Group Plc?
Mereo Biopharma Group Plc (0A9G) Ownership Overview
- 0.81% Insiders
- 0.04% Mutual Funds
- 0.07% Other Institutional Investors
- 99.08% Public Companies and Individual Investors
The ownership structure of Mereo Biopharma Group Plc (GB:0A9G) stock is a mix of institutional, retail, and individual investors. Approximately 0.11% of the company’s stock is owned by Institutional Investors, 0.81% is owned by Insiders, and 99.08% is owned by Public Companies and Individual Investors.
The ownership structure of Mereo Biopharma Group Plc (GB:0A9G) stock is a mix of institutional, retail, and individual investors. Approximately 0.11% of the company’s stock is owned by Institutional Investors, 0.81% is owned by Insiders, and 99.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | $48,374 | |
| Dec 31, 2025 | Entrypoint Capital, Llc | $166,691 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Denise Pollard-knight | 808,921 | Insider | 0.51% | 233,778 |
| Andrew Alkon | 400,700 | Institution | 0.25% | 115,802 |
| Charles Sermon | 219,061 | Insider | 0.14% | 63,309 |
| Kenneth Tropin | 116,286 | Institution | 0.07% | 33,607 |
| John Lewicki | 92,826 | Insider | 0.06% | 26,827 |
| Fox Christine Ann | 89,285 | Insider | 0.06% | 25,803 |
| BlackRock, Inc. | 69,678 | Institution | 0.04% | 20,137 |
| Trust For Professional Managers | 55,903 | Institution | 0.04% | 16,156 |
| Hughes-wilson Alexandra | 50,475 | Insider | 0.03% | 14,587 |
| Michael Wyzga | 25,050 | Insider | 0.02% | 7,239 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Trust For Professional Managers | 55,903 | Institution | 0.04% | 16,156 |
FAQ
Who Owns Mereo Biopharma Group Plc (GB:0A9G)?
According to the latest TipRanks data, approximately 0.11% of the company's stock is held by institutional investors, 0.81% is held by insiders, and 99.08% is held by public companies and individual investors.
What percentage of Mereo Biopharma Group Plc (GB:0A9G) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.11% of Mereo Biopharma Group Plc (GB:0A9G) stock is held by institutional investors: 0.04% by mutual funds and 0.07% by other institutional investors.
What percentage of Mereo Biopharma Group Plc (GB:0A9G) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.08% of Mereo Biopharma Group Plc (GB:0A9G) stock is held by public companies and individual investors.
Who owns the most shares of Mereo Biopharma Group Plc (GB:0A9G)?
Denise Pollard-Knight owns the most shares of Mereo Biopharma Group Plc (GB:0A9G).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
